He Huang
Chongqing, Chongqing Municipality, 4000000, China
Location status: Recruiting
NCT Number: NCT06281431
Surgical pain is a common complication after surgery, affecting patient recovery and treatment quality. >20% of patients suffer from chronic postoperative pain. China has >70 million surgeries yearly. Nerve block manages postoperative pain, with developing nerve block needles now used in clinics. Developed needles may have better pain management effects than non-developed ones, but their effect on reducing chronic pain remains unclear. This study aims to explore the effect of developed nerve block needles on postoperative pain and compare them to non-developed needles, providing new ideas and methods for pain management.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Chongqing, Chongqing Municipality, 4000000, China
Location status: Recruiting
Surgical pain is one of the common complications after surgery, which seriously affects the recovery and treatment quality of patients. More than 20% of patients will suffer from postoperative chronic pain. According to the data of the National Bureau of Statistics, there are more than 70 million surgeries in China every year. Nerve block is one of the most commonly used methods for postoperative pain management in clinical practice. In recent years, the developing nerve block needle has gradually begun to be used in clinical practice. Compared with the ordinary non-developing nerve block needle, it may have a better effect on pain management after surgery, but whether it has a reduction effect on chronic pain after surgery is still unknown. The purpose of this study is to explore the effect of developing nerve block needle on postoperative pain, and to compare the difference between it and the common non-developing nerve block needle, so as to provide new ideas and methods for postoperative pain management.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 22G 8-cm echogenic nerve block needle (LEAPMED, CHINA) is selected for the procedure, administered under ultrasound guidance. Subsequently, a volume of 20 ml 0.375% ropivacaine is injected at the needle's tip for analgesic effect. The spread of the medication will be assessed through short- and long-axis imaging perspectives. Following this, evaluations are conducted to assess acute postoperative pain as well as chronic postoperative pain. Parameters such as the duration of nerve blockade, the incidence of punctures, and any associated complications are all meticulously appraised.
A 22G 8-cm thin wall low bottom nerve block needle (KDL, CHINA) is selected for the procedure, administered under ultrasound guidance. Subsequently, a volume of 20 ml 0.375% ropivacaine is injected at the needle's tip for analgesic effect. The distribution of the medication will be assessed using short- and long-axis imaging perspectives. Following this, evaluations are conducted to assess acute postoperative pain as well as chronic postoperative pain. Parameters such as the duration of nerve blockade, the number of punctures, and any associated complications are all meticulously appraised.
Time frame: The third month after surgery.
Incidence of Chronic pain assessment from 3 months after surgery
Time frame: from end of surgery to 24 hours after surgery.
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
Time frame: From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
Time frame: From return to the ward to 12 hours after return to the ward
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
Time frame: From 12 hours after return to the ward to 24 hours after return to the ward
Pain intensity (assessed by number rating scale, 0 represents no pain, 10 represents intolerable pain) more than 4
Time frame: From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
Time from needle insertion to needle extraction
Time frame: From the ending of surgery to leaving the postanesthesia care unit, an average of 30 minutes
The number of times the needle is withdrawn more than 2 cm and resited
Contact information is provided by the study sponsor or research team.
Da gang Wang, ph.D
CONTACT
He Huang, ph.D
CONTACT
The Second Affiliated Hospital of Chongqing Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06585033
Chronic Pain, Chronic Postoperative Pain
Arnhem, Netherlands
View Trial DetailsNCT01388946
Chronic Pain, Chronic Postoperative Pain
Athens, Greece
View Trial DetailsNCT01510496
Chronic Pain, Chronic Postoperative Pain
Badalona, Barcelona, Spain
View Trial DetailsNCT07640646
Cardiac Surgery, Chronic Postoperative Pain
Leuven, Vlaams Brabant, Belgium
View Trial Details